To aid surgical and healing process in patients, Brookes Pharmaceuticals – a Pakistan-based pharma company, in collaboration with Pharmaplus Nigeria Limited, has unveiled Pyodine range of antiseptics into the Nigerian pharma market.
The unveiled products included Pyodine Solution (60ml & 450ml), Pyodine Surgical Scrub, Pyodine Gargle & Mouth Wash (for oral & throat care) and Pyodine Gel.
The colourful ceremony, which took place at Sheraton Hotel, Ikeja GRA, Lagos, on 30 July, 2019, had eminent pharmacists, nurses, doctors and several dignitaries in attendance.
In his welcome remark at the event, Pharm. Ahmed Yakasai, managing director, Pharmaplus Nigeria Limited, explained that, as a past president of the Pharmaceutical Society of Nigeria (PSN), he understands the importance of safety and quality assurance.
“It is not only about quality, the safety of patients should be utmost in the mind of every health worker,” he said.
Yakasai, who is fondly called “Consul-General of Pakistan in Nigeria,” disclosed that his attention was drawn to the quality of pharmaceuticals in Pakistan by the late Director General of National Agency for Food and Drug Administration and Control (NAFDAC), Dr Dora Akunyili.
“With that in mind, I can confidently tell you that there is no better product range presently in the market than Pyodine. It is a broad spectrum antiseptic for wound care,” he stressed.
In his address, Major Gen. Waqar Ahmad Kingravi (retd), high commissioner of Pakistan to Nigeria, congratulated both companies doing the unveiling, adding that in the whole of Pakistan, Brookes Pharma stands out as a leader in producing premium and affordable antiseptics.
“Beyond that, Pakistan is a vibrant country that boasts of great pharma companies. The industry is open for collaboration, deliberation and cooperation with pharma companies in Nigeria.
“Once again, I congratulate Yakasai and Brookes on this novel products unveiling and wish them all the best,” Kingravi remarked.
Appreciating the audience, Adnan Ali Khan, director, global business, Brookes Pharmaceuticals, announced that he was pleased to visit Nigeria whose pharma industry he admires so much.
“We are proud to be the brand leader in the antiseptic market, with our dedicated and fully automated manufacturing facility. If you ask me, I would say our brand is known more than our company in almost all private, public and government hospitals,” he enthused.
While reiterating that Brookes is into management of chronic wounds treatment, the director also declared that his company welcomes constructive criticism, suggestion and direction on ways to improve on the brands.
Apparently impressed with the product launch, Pharm. Anthony Oyawole, former PSN presidential aspirant, opined that he hoped the quality be sustained.
“In attestation of Yakasai’s vision of quality pharmaceutical service, He has come to demonstrate it. One thing is preaching, another is practising it. Indeed, he is a man of his word,” he declared.
In a related development, Santosh Kumar, managing director, Worldwide Commercial Ventures (WWCV) has announced that he is proud to be associated with Yakasai and Brookes Pharma.
“WWCV has a track record of distributing top quality products over the years and we have no doubt that Pyrodine will do well,” he said.
Pharm. Chibuzor Opara, co-founder, DrugStoc Nigeria Limited, seemed to be in agreement with this view.
In his words, “We are quite excited about the products after our findings from the research we carried out. I think Brookes has done well. I want to thank Yakasai and WWCV for getting it across to Nigerians. The industry will benefit a lot from it.”
Additionally, Pharm. Margaret Obono, director of pharmacy and head of pharmacy department, National Orthopaedic Hospital, Igbobi has endorsed the newly unveiled products.
She said, “As a hospital pharmacist, most antiseptic products you see around are so expensive. The affordable ones we had in the past also disappeared after sometime.
“When I heard about these products through Yakasai, I was happy because he has pedigree and integrity. That is why I came here today with the nursing head of the orthopaedic hospital.”
Other dignitaries in attendance included Pharm. Ade Popoola, managing director, Reals Pharmaceuticals; Sir Ifeanyi Atueyi, managing director, Pharmanews Limited; Adham Yehia, co-founder, DrugStoc Nigeria Limited; Dr Arif Siddiqui, advisor on regulatory & marketing affairs, Brookes Pharma; Sandar Rahin, assistant secretary, commercial, Pakistan High Commission and Tahir Abbas, commercial secretary, Pakistan High Commission.
Brookes Pharma began with the establishment of a nascent pharmaceutical company based on a philosophy that regarded quality as the highest value in 1986.
It started out with production of injectible products – a segment that needs great sophistication of equipment and expertise. Brookes was also the first pharmaceutical of Pakistan to introduce research novelties for treatment of liver related diseases.
The pharmaceutical giant is equally the foremost national company to have 4 international certifications including ISO-9001, ISO-14001, ISO-17025, OHSAS-18001 certifications. Aside maintaining a world class standard of quality in operations, it has continually expanded its portfolio with timely introduction of new molecules.
Today, Brookes’ products are available in top pharmacies in Sri Lanka, Kenya, Vietnam, Tanzania, Philippines Uganda, Sudan, Myanmar, Uzbekistan and Afghanistan.